Huiling Yang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Huiling Yang

Showing results (151-160 of 156) with videos related to

Pageof 16

Sort By:

You have reached the last page of results.This site can display upto 156 results.

Journal of Medicinal Chemistry|February 12, 2014

Highly potent HCV NS4B inhibitors with activity against multiple genotypesBarton Phillips, Ruby Cai, William Delaney, et al.

Antimicrobial Agents and Chemotherapy|August 14, 2013

Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451Huiling Yang, Margaret Robinson, Amoreena C Corsa, et al.

Cancer Letters|May 2, 2025

Mutant p53 confers chemoresistance by activating KMT5B-mediated DNA repair pathway in nasopharyngeal carcinomaHaidan Luo, Mo-Fan Huang, An Xu, et al.

Antimicrobial Agents and Chemotherapy|July 13, 2011

Mechanistic characterization of GS-9190 (Tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymeraseI-Hung Shih, Inge Vliegen, Betty Peng, et al.

Bioorganic & Medicinal Chemistry Letters|March 10, 2017

Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable propertiesThorsten A Kirschberg, Sammy Metobo, Michael O Clarke, et al.

Scientific Reports|February 23, 2023

Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitroSheli R Radoshitzky, Patrick Iversen, Xianghan Lu, et al.

Pageof 16

Search research articles

Showing results (151-160 of 156) with videos related to

Sort By:

Pageof 16

You have reached the last page of results.This site can display upto 156 results.

Journal of Medicinal Chemistry|February 12, 2014

Highly potent HCV NS4B inhibitors with activity against multiple genotypesBarton Phillips, Ruby Cai, William Delaney, et al.

Antimicrobial Agents and Chemotherapy|August 14, 2013

Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451Huiling Yang, Margaret Robinson, Amoreena C Corsa, et al.

Cancer Letters|May 2, 2025

Mutant p53 confers chemoresistance by activating KMT5B-mediated DNA repair pathway in nasopharyngeal carcinomaHaidan Luo, Mo-Fan Huang, An Xu, et al.

Antimicrobial Agents and Chemotherapy|July 13, 2011

Mechanistic characterization of GS-9190 (Tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymeraseI-Hung Shih, Inge Vliegen, Betty Peng, et al.

Bioorganic & Medicinal Chemistry Letters|March 10, 2017

Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable propertiesThorsten A Kirschberg, Sammy Metobo, Michael O Clarke, et al.

Scientific Reports|February 23, 2023

Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitroSheli R Radoshitzky, Patrick Iversen, Xianghan Lu, et al.

Pageof 16